Navigation Links
KemPharm, Inc. Announces Positive Results from Phase 1 Trial of KP201 for Pain
Date:5/24/2011

NORTH LIBERTY, Iowa, May 24, 2011 /PRNewswire/ -- KemPharm, Inc. today announced positive results from a Phase 1 clinical trial of its most advanced opioid-based drug candidate, KP201, a novel hydrocodone prodrug for treating pain.  KP201 is a new chemical entity (NCE) composed of hydrocodone chemically bound to a ligand.

The data confirmed that KP201 is cleaved in man as predicted, releasing the active pharmaceutical compound hydrocodone into the bloodstream at amounts equivalent to the reference listed drug (RLD), Norco®.  Importantly, intact KP201 could not be detected in systemic circulation, indicating that minimal additional studies are warranted to determine the impact of KP201 exposure in the body.

"Our findings from this first clinical trial of KP201 are as good as we could have hoped," stated Sven Guenther, Ph.D., Vice President of Research at KemPharm. "The human pharmacokinetic profile of KP201 indicates that the prodrug releases hydrocodone efficiently and is bioequivalent to the comparator drug, supporting a 505(b)(2) regulatory pathway for KP201 in combination with acetaminophen. KP201 has unique physiochemical and pharmacological attributes that deliver additional patient benefits, including reduced potential for abuse as well as reduction or elimination of opioid-induced constipation."

The Phase 1 study was a single dose, three-treatment, three-period, six-sequence, cross-over PK study in which twenty-four healthy volunteers received oral doses of 5 mg KP201, 10 mg KP201, or 10/325 mg tablet of hydrocodone bitartrate and acetaminophen (Norco®, RLD).  The objectives of the study included evaluation of the serum concentrations of hydrocodone, certain metabolites, and intact KP201, as well as safety and tolerability.

"We believe KP201 has the potential to assume sizeable market share, given the opportunity for extended market exclusivity in acute and chronic pain, as well as the potential to mi
'/>"/>

SOURCE KemPharm, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. KemPharm, Inc. Receives Notice of Issuance From USPTO on Patent Protecting Companys ADHD Prodrug Technology
2. KemPharm, Inc. Receives Notice of Issuance from USPTO on Second Patent Protecting Companys ADHD Prodrug Technology
3. KemPharm, Inc. Announces Plans to Launch KP106 as First Oral Film Dosage Form for ADHD
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... N.J. , Oct. 22, 2014  Quest Diagnostics ... of diagnostic information services, today announced that its Board ... serve as a director, effective December 1, 2014. Including ... Dr. Leiden is the Chairman, President and CEO of ... years of scientific and commercial experience in the pharmaceutical ...
(Date:10/22/2014)... , Oct. 22, 2014   Reproductive Medicine ... leader in the field of infertility, presents new ... embryonic screening. The research abstract, released during the ... Medicine (ASRM) meeting in Honolulu, Hawaii ... single gene defect (SGD) pre-implantation genetic diagnosis (PGD). ...
(Date:10/22/2014)... A new report by Allied ... Form, End user, Application and Geography) - Size, Share, ... Opportunities, Segmentation and Forecast, 2013 - 2020", considers commercial ... key trends tracked, it is anticipated that the market ... 2020, registering a CAGR of 6.2% from 2014 to ...
Breaking Medicine Technology:Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 2Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 3New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 2New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 3Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 2Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 3Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 4
... Reduced Seizures in Patients ... Who Were Inadequately Controlled, ... published data show that Lamictal(R)XR(TM) (lamotrigine) Extended-,Release Tablets significantly ... with epilepsy. Lamictal XR is an extended-release formulation ...
... Patient Recruitment Starting Now -- For More Information, Call 888-345-7774 ... or Visit Our Website at ... Trials announced today,that it is now screening patients for enrollment ... Phase III studies to evaluate the,efficacy, safety and tolerability of ...
Cached Medicine Technology:New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy 2New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy 3New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy 4
(Date:10/22/2014)... October 22, 2014 Isabel Healthcare ... Allied Health Professions (ASAHP) Conference on October 22-24 in ... will participate in a panel discussion on Technology in ... Isabel Healthcare provides a diagnostic decision support tool and ... diagnosis skills of students and clinical learners. The Isabel ...
(Date:10/22/2014)... The United States is now mandating that all ... Africa land at one of five airports equipped ... In a statement released Tuesday, Homeland Security ... air passengers from Guinea, Liberia and Sierra Leone ... -- New York City,s Kennedy International Airport, Washington ...
(Date:10/22/2014)... 2014 Hay House is pleased to announce ... Upgrade Your Life (Paperback; $10.82) written by the highly esteemed ... This book is meant to help readers of all ... recovery. , Recovery 2.0 is not the average self-help ... is a guide for what comes next. For ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Best Cheap ... in the world. The site has recently announced that ... hosting supplier for people from around the world. , ... in operation today and is providing various kinds of ... the company insists on offering excellent customer service and ...
(Date:10/22/2014)... there are only 24 hours in a day, that doesn’t seem ... time within their busy schedules for exercise and fitness. Fortunately, one ... get in shape. Here are five ways you can reach your ... Up Your Commute , Consider riding a bike or taking the ... daily routine. If you must use your car to get to ...
Breaking Medicine News(10 mins):Health News:Isabel Healthcare to Participate in The Association of Schools of Allied Health Professions (ASAHP) 2014 Conference 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 3Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 3Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2
... ... control services, is proud to announce the launch of their TV advertisement campaign featuring the ... ... advertising campaign will air on stations across California as well as in Reno, NV. ...
... ... important secrets have been kept from the public about the manipulation ... in the health care reformation debacle. Author of "The American Medical ... insights contained in his new work, now available on Amazon and ...
... San Diego, CA, April 6, 2010 Poisoning is now ... U.S. While several recent high-profile Hollywood celebrity cases have brought ... deaths have been on the rise for more than 15 ... crashes as the leading cause of unintentional injury death among ...
... Women with breast cancer before age 55 who carry ... BRCA1 or BRCA2 are four times more likely to ... their initial tumor as compared to breast cancer patients ... Cancer Research Center breast cancer epidemiologist Kathleen Malone, Ph.D., ...
... of Wisconsin-Madison, one of the most powerful magnetic ... pregnant patients for rare but very serious fetal ... The Medical College of Wisconsin, Milwaukee; Children,s Hospital ... the ultrasensitive detector measures magnetic signals coming from ...
... relatives who also drink, study finds , MONDAY, April 5 ... more likely to imbibe a bit too much themselves. , ... non-drinking friends and relatives are more likely not to consume ... by their drinking behavior more than would be predicted by ...
Cached Medicine News:Health News:Marysville Girl Stars in TV Advertising Campaign 2Health News:Health Care Reform's Hidden Racket Exposed 2Health News:Health Care Reform's Hidden Racket Exposed 3Health News:Health Care Reform's Hidden Racket Exposed 4Health News:Poisoning by prescription drugs on the rise 2Health News:Breast cancer patients with BRCA mutations 4 times more likely to get cancer in opposite breast 2Health News:Breast cancer patients with BRCA mutations 4 times more likely to get cancer in opposite breast 3Health News:Breast cancer patients with BRCA mutations 4 times more likely to get cancer in opposite breast 4Health News:Ultrasensitive detector pinpoints big problem in tiny fetal heart 2Health News:Ultrasensitive detector pinpoints big problem in tiny fetal heart 3Health News:Ultrasensitive detector pinpoints big problem in tiny fetal heart 4Health News:Your Social Network Affects Your Drinking Habits 2Health News:Your Social Network Affects Your Drinking Habits 3
... The SmartDriver System consists of a pistol-grip ... Power, with a wide range of couplers ... of orthopedic surgical applications., ,The Battery ... speed compared to the original Battery SmartDriver. ...
... is an evolutionary product for the inside-out ... designed specifically for use with the Collagen ... becoming a new standard for use in ... a unique method to deliver sutures using ...
... Release System is a technological breakthrough in ... a minimally-invasive approach, provides significant patient benefits. ... of the wrist,creates an entry for the ... a standard video camera system, provides a ...
... a safe alternative to using positive displacement ... such as PCR(a), pipetting radioactive materials and ... excellent for tissue culture, gel loading, serological ... aerosol contaminants and liquids from reaching the ...
Medicine Products: